Update in Genetics and Surgical Management of Primary Congenital Glaucoma

• Main Authors: Mehmet C. Mocan, Amy A. Mehta, Ahmad A. Aref
• Format: Article
• Language: English
• Published: Galenos Yayinevi 2019-12-01
• Series: Türk Oftalmoloji Dergisi
• Subjects: primary congenital glaucoma; genetics; angle surgery; glaucoma drainage implants
• Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/update-in-genetics-and-surgical-management-of-prim/34582
• ISSN: 1300-0659; 2147-2661

Primary congenital glaucoma (PCG) continues to be an important cause of visual impairment in children despite advances in medical and surgical treatment options. The progressive and blinding nature of the disease, together with the long lifespan of the affected population, necessitates a thorough understanding of the pathophysiology of PCG and the development of long-lasting treatment options. The first part of this review discusses the genetic features and makeup of this disorder, including all currently identified genetic loci (GLC3A, GLC3B, GLC3C and GLC3D) and relevant protein targets important for trabecular and Schlemm canal dysgenesis. These target molecules primarily include CYP1B1, LTBP2, and TEK/Tie2 proteins. Their potential roles in PCG pathogenesis are discussed with the purpose of bringing the readers up to date on the molecular genetics aspect of this disorder. Special emphasis is placed on functional implications of reported genetic mutations in the setting of PCG. The second part of the review focuses on various modifications and refinements to the traditional surgical approaches performed to treat PCG, including advances in goniotomy and trabeculotomy ab externo techniques, glaucoma drainage implant surgery and cyclodiode photocoagulation techniques that ultimately provide safer surgical approaches and more effective intraocular pressure control in the 21st century.